Bush Administration Considering Physician Ratings

Publication
Article
OncologyONCOLOGY Vol 15 No 7
Volume 15
Issue 7

Thomas Scully, the new administrator of the Health Care Financing Administration, is moving fast to make improvements to Medicare. A proposal to collect and publish quality and outcome information on health-care practitioners who treat

Thomas Scully, the new administrator of the Health CareFinancingAdministration, is moving fast to make improvements to Medicare.A proposal to collect and publish quality and outcome information on health-carepractitioners who treat Medicare patients will apparently be included in apackage of reforms that Mr. Scully plans to unveil.

In a speech at the USChamber of Commerce, Mr. Scully said he had a mandate to "shake up"the agency. He said the Bush administration would give the elderly moreinformation on their health insurance options, and publicize data on the qualityof care provided by hospitals, doctors, nursing homes, and home care agencies.

Sen. Bill Frist (R-Tenn), formerly a practicing physician, welcomed the overhaulbut said the administration must be careful to include hospitals and others inthe deliberations. "We need to make sure that we don’t unduly increasethe burdens on doctors and health-care providers who already face increasingregulatory constraints,’’ he said. Mr. Scully has not disclosed what kind ofratings system he has in mind.

Experiments with physician systems in Portland,Oregon, and Cincinnati, Ohio, have left some physicians exasperated. NationalResearch Corp, headquartered in Lincoln, Nebraska, rated primary care physiciansin those two cities in four areas of "care." Health plans in thosecities provided the names of patients and physicians.

"Our response was, it’sworthless," said Jim Kronenberg, associate executive director of thePortland-based Oregon Medical Association. "It’s got this sort of MickeyMouse seal of approval without any real hard data."

Recent Videos
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Genetic backgrounds and ancestry may hold clues for better understanding pancreatic cancer, which may subsequently mitigate different disparities.
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Thomas Hope, MD, believes that an NRC initiative to update infiltration guidelines may organically address concerns that H.R. 2541 outlines.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
4 experts are featured in this series.
4 experts are featured in this series.
Thomas Hope, MD, had not observed an adverse effect attributable to an infiltration across more than a decade of administering nuclear agents at UCSF.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
Related Content